Ribomic Companies
RIBOMIC develops molecularly targeted pharmaceutical drugs using RNA aptamers. The co-discovery division earns the alliance partner's research expenses for the shared part of co-discovery business with alliance pharmaceutical companies researching aptamer pharmaceutical.
Founded Date:
2003
Technology:
Advanced and Next Generation Therapies (Various)
Headquarters:
Minato, Chiba, Japan
Industry:
Healthcare Innovations